title: Current estimate of costs of lung cancer screening in the United States.
abstract: The United States Preventive Services Task Force recently endorsed the use of low-dose computed tomography for lung cancer screening in high-risk patients because of the potential to reduce deaths. Before implementation on a national level, it will be important to ensure that a safe, high-quality, and accessible service can be adequately provided. It will also be important to make sure that screening is cost-effective. This article summarizes the published analyses of lung cancer screening cost, provides a contemporary estimation of the annual cost of screening in the United States, and identifies areas for improvement in the future.
authors.affiliation: Division of Cardiothoracic Surgery, University of Colorado School of Medicine, 12631 East 17th Avenue, C-310, Aurora, CO 80045, USA.
authors.forename: David C
authors.initials: DC
authors.lastname: Mauchley
authors.affiliation: Division of Cardiothoracic Surgery, University of Colorado School of Medicine, 12631 East 17th Avenue, C-310, Aurora, CO 80045, USA. Electronic address: john.mitchell@ucdenver.edu.
authors.forename: John D
authors.initials: JD
authors.lastname: Mitchell
mesh_terms: D003362:Cost-Benefit Analysis; D055088:Early Detection of Cancer / Q000191:economics* / Q000379:methods; D005102:Health Expenditures; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging*; D008403:Mass Screening / Q000191:economics* / Q000379:methods; D011879:Radiotherapy Dosage; D012306:Risk; D014057:Tomography, X-Ray Computed / Q000191:economics* / Q000379:methods; D014481:United States
keywords: Budget impact model; Cost-effectiveness; Early Lung Cancer Action Project (ELCAP); Low-dose computed tomography (LDCT); Lung cancer screening; National Lung Screening Trial (NLST)